Stock Fundamentals

Company Information

Company Name
LifeMD Inc
Sector
Healthcare
Industry
Health Information Services
Exchange
NASDAQ
ISIN: US53216B1044
CIK: 0000948320
CUSIP: 53216B104
Currency: USD
Full Time Employees: 347
Phone: 866 351 5907
Fiscal Year End: December
IPO Date: Jan 02, 2001
Description:

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Address:

236 Fifth Avenue, New York, NY, United States, 10001

Directors & Officers

Name Title Year Born
Mr. Justin Schreiber Chairman & CEO 1983
Ms. Shayna Webb Dray Chief Operating Officer 1987
Mr. Stefan Galluppi Chief Innovation Officer 1987
Mr. Atul Kavthekar Chief Financial Officer NA
Ms. Maria E. Stan CPA Chief Accounting Officer & Controller 1975
Mr. Dennis Wijnker Chief Technology Officer 1976
Mr. Eric H. Yecies Chief Legal Officer, General Counsel & Corporate Secretary 1978
Mr. Shane Biffar Chief Compliance Officer & Deputy General Counsel 1983
Mr. Chris Pisano Chief Marketing Officer 1975
Mr. Nicholas P. Alvarez Chief Acquisition Officer & Head of Customer Acquisition 1982

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 09, 2025 Jessica Friedeman N/A Sale 15.00K $3.61 $54.15K
Sep 10, 2025 Nicholas P Alvarez N/A Sale 75.00K $5.92 $444.00K
Jul 01, 2025 Justin Schreiber N/A Sale 25.00K $13.38 $334.50K
Jun 17, 2025 Marc David Benathen N/A Sale 50.00K $14.01 $700.50K
Jun 16, 2025 Marc David Benathen N/A Sale 75.00K $13.09 $981.75K
Jun 13, 2025 Eric Harold Yecies N/A Sale 15.00K $12.25 $183.75K
Jun 13, 2025 Stefan Galluppi N/A Sale 85.00K $12.38 $1.05M
Jun 02, 2025 Justin Schreiber N/A Sale 25.00K $12.47 $311.75K
May 01, 2025 Justin Schreiber N/A Sale 22.00K $7.53 $165.62K
Apr 29, 2025 Justin Schreiber N/A Sale 50.00K $7.78 $389.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 2.81M Mar 31, 2026 5.91% $0.00 -0.20%
Vanguard Group Inc 2.02M Dec 31, 2025 4.25% $0.00 -9.21%
Royce & Associates, LP 1.20M Mar 31, 2026 2.53% $0.04 32.10%
Renaissance Technologies Corp 1.12M Mar 31, 2026 2.35% $0.01 -25.36%
State Street Corp 1.08M Mar 31, 2026 2.26% $0.00 0.19%
Geode Capital Management, LLC 1.02M Mar 31, 2026 2.14% $0.00 6.23%
Federated Hermes Inc 1.02M Mar 31, 2026 2.14% $0.01 3.96%
Prescott Group Capital Management LLC 895.42K Mar 31, 2026 1.88% $0.32 30.28%
BRC Group Holdings Inc 871.58K Mar 31, 2026 1.83% $0.69 1,077.81%
Susquehanna International Group, LLP 465.19K Mar 31, 2026 0.98% $0.00 45.68%
The Goldman Sachs Group Inc 459.80K Mar 31, 2026 0.97% $0.00 75.20%
Jane Street Group LLC 366.67K Mar 31, 2026 0.77% $0.00 65.84%
Morgan Stanley - Brokerage Accounts 364.49K Mar 31, 2026 0.77% $0.00 11.74%
Whetstone Capital Advisors, LLC 360.25K Mar 31, 2026 0.76% $0.45 -48.76%
Northern Trust Corp 334.81K Mar 31, 2026 0.70% $0.00 8.98%
UBS Group AG 282.10K Mar 31, 2026 0.59% $0.00 -58.15%
Marshall Wace Asset Management Ltd 257.14K Mar 31, 2026 0.54% $0.00 0.00%
Bank of New York Mellon Corp 240.94K Mar 31, 2026 0.51% $0.00 -5.77%
AQR Capital Management LLC 198.32K Mar 31, 2026 0.42% $0.00 297.06%
Barry Investment Advisors, LLC 171.89K Mar 31, 2026 0.36% $0.14 0.00%

Shares Statistics

Shares Outstanding: 48.36M
Shares Float: 40.08M
% Insiders: 1,446.80%
% Institutions: 3,718.60%
Short % Float: 14.47%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.13M 2.37% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 933.68K 1.96% ▲ 0.85% Apr 30, 2026
3 Royce Small-Cap Opportunity Invmt 618.72K 1.30% ▲ 24.95% Mar 31, 2026
4 FTGF RY US SmCp Opp A USD Dis(A) 554.07K 1.17% ▲ 23.31% Mar 31, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 495.22K 1.04% ▲ 0.00% Apr 30, 2026
6 Federated Hermes MDT SCC Institutional 409.65K 0.86% ▲ 0.00% Mar 31, 2026
7 Federated Hermes MDT Small Cap Core IS 409.65K 0.86% ▲ 0.00% Mar 31, 2026
8 Fidelity Small Cap Index 379.24K 0.80% ▼ 0.40% Feb 28, 2026
9 Bridge Builder Small/Mid Cap Growth 345.81K 0.73% ▲ 8.71% Apr 30, 2026
10 Stt Strt®SPDR®S&PKenshoNwEcosComposETF 317.40K 0.67% ▲ 0.05% Apr 30, 2026

Valuation Metrics

Enterprise Value: $196.34M
Trailing P/E: 0.00
Forward P/E: 12.85

Financial Highlights

Market Cap: $226.82M
EBITDA: $-14.30M
Book Value: $0.32
Earnings/Share: $-0.44
Profit Margin: 2.93%
Operating Margin: -17.80%
ROA (TTM): -13.41%
ROE (TTM): -238.45%
Revenue (TTM): $193.33M
Revenue/Share (TTM): $4.19
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -1.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.25x 0.03x 0.67x -5.64x -1.78x
2024-12-31 0.81x -3.43x 1.06x -7.40x -2.83x
2023-12-31 1.22x 5.38x 0.90x -5.58x -2.39x
2022-12-31 0.36x -0.52x 1.28x -34.05x -0.09x
2021-12-31 1.97x 0.02x 0.48x -17.98x -0.01x
2020-12-31 0.89x 0.64x 1.06x -34.67x -0.02x
2019-12-31 0.69x -0.82x 1.33x -3.80x -0.32x
2018-12-31 1.35x 0.28x 0.69x -5.80x -0.13x
2017-12-31 1.97x 0.19x 0.51x -10.62x -0.16x
2016-12-31 0.69x -0.58x 1.46x -24.16x -0.18x
2015-12-31 1.68x 1.00x 0.60x -7.00x -1.10x
2014-12-31 0.44x -0.19x 1.80x -113.36x -0.07x
2013-12-31 1.38x 0.21x 0.65x -161.42x -0.18x
2012-12-31 1.13x 0.00x 0.63x -160.20x 0.00x
2011-12-31 0.23x -0.93x 1.82x -27.11x -0.59x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about LFMD.US!